Skip to content

Biodesix, Inc. BDSX Income Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$96.1M+8.6%$88.5M+10.4%$80.17M+4.7%$76.56M+2.8%$74.46M+4.4%
$12.42M+3.5%$12M+3.9%$11.55M+4.0%$11.1M+6.8%$10.39M+8.7%
$91.36M+4.4%$87.55M+3.2%$84.79M+2.0%$83.09M+3.4%$80.34M-0.1%
$121.03M+4.0%$116.37M+3.2%$112.73M+1.9%$110.65M+3.3%$107.08M+1.2%
-$24.94M+10.5%-$27.87M+14.4%-$32.56M+4.5%-$34.1M-4.5%-$32.61M+5.5%
-26%+5.5pp-31.5%+9.1pp-40.6%+3.9pp-44.5%-0.7pp-43.8%+4.6pp
$8.01M+3.8%$7.72M+4.1%$7.41M+0.4%$7.38M-0.5%$7.41M-10.2%
-$7.02M+5.0%-$7.39M-5.9%-$6.98M0.0%-$6.98M+10.5%-$7.81M+7.4%
-$31.96M+9.4%-$35.27M+10.8%-$39.54M+3.8%-$41.08M-1.6%-$40.42M+5.9%
-33.3%+6.6pp-39.8%+9.5pp-49.3%+4.3pp-53.7%+0.6pp-54.3%+5.9pp
-$2.48+22.3%-$3.19+15.8%-$3.79+6.0%-$4.030.0%-$4.03-52.1%
-$19.31M+13.0%-$22.2M+17.2%-$26.82M+5.1%-$28.28M-5.4%-$26.82M+6.6%
-20.1%+5.0pp-25.1%+8.4pp-33.5%+3.5pp-36.9%-0.9pp-36%+4.3pp
-$24.94M+10.5%-$27.87M+14.4%-$32.56M+4.5%-$34.1M-4.5%-$32.61M+5.5%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Biodesix, Inc.'s revenue?
Biodesix, Inc. (BDSX) generated $96.1M in revenue over the trailing twelve months, up 29.0% year over year.
Is Biodesix, Inc. profitable?
Biodesix, Inc. is not currently profitable: it reported a net loss of $32.0M over the trailing twelve months, a -33.3% net margin.
What is Biodesix, Inc.'s earnings per share?
Biodesix, Inc.'s diluted EPS over the trailing twelve months is $-2.48.
Where does Biodesix, Inc.'s income statement data come from?
Every line is extracted from Biodesix, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.